Shristy S. Tiwari

In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites

Balasaheb B. Chavan, Shristy S. Tiwari, G. Shankar et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 46 citations

Life Sciences, Pharmacokinetics, Pharmacology +14

Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity

Vivek Dhiman, Ankit Balhara, Saranjit Singh et al. · Journal of Pharmaceutical and Biomedical Analysis · 2021 · 24 citations

Pharmacy, Toxicology, Mechanisms Of Toxicity +12

In vitroand in vivo investigation of metabolic fate of riociguat by HPLC-Q-TOF/MS/MS and in silico evaluation of the metabolites by ADMET predictor™

Shristy S. Tiwari, Balasaheb B. Chavan, Bhoopendra Singh Kushwah et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 21 citations

Life Sciences, Pharmacokinetics, Pharmacology +17

Stability behaviour of antiretroviral drugs and their combinations. 3: Characterization of interaction products of emtricitabine and tenofovir disoproxil fumarate by mass spectrometry

Moolchand Kurmi, Dilip Kumar Singh, Shristy S. Tiwari et al. · Journal of Pharmaceutical and Biomedical Analysis · 2016 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh‐performance liquid chromatography/quadrupole time‐of‐flight tandem mass spectrometry

Balasaheb B. Chavan, Pradipbhai D. Kalariya, Shristy S. Tiwari et al. · Rapid Communications in Mass Spectrometry · 2017 · 15 citations

Medicine, Pharmacology, Psychiatry +17